Volume 35, 2 April 2004 4/2004
 
  SPOT ON
 

Adjuvant treatment of breast cancer: early switch to exemestane (AROMASIN)?

 
  NEW ON THE MARKET
 

Fulvestrant (FASLODEX) for advanced breast cancer

 
  REVIEW
 

Drug-eluting stents

 
  THERAPIES FROM A CRITICAL VIEW POINT
 

Infliximab (REMICADE) for fistulising CROHN's disease
Acute coronary syndrome: Atorvastatin better than Pravastatin?

 
  QUALITY ASSESSMENT
 

Quality of enalapril (e.g. PRES) products

 
  BEWARE! MISSINFORMATION
 

Pimecrolimus (e.g. ELIDEL) for atopic dermatitis
Prophylaxis of migraine headaches with butterbur root (PETADOLEX):
standard of treatment according to a new guideline?

 
  IN BRIEF
 

Prematurity and chronic lung disease: late outcomes of dexamethasone therapy
Patent expiration for carvedilol (DILATREND, QUERTO)
Antibacterial products in households unneccessary

 
  CURRENT ADR NETWORK REPORT

Long-acting injectable risperidone (RISPERDAL CONSTA):
anxiety and aggressive outbursts

 
© arznei-telegramm 4/2004